首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical and genetic characteristics of cystic fibrosis in CHINESE patients: a systemic review of reported cases
Authors:Xiaobei Guo  Keqiang Liu  Yaping Liu  Yusen Situ  Xinlun Tian  Kai-Feng Xu  Xue Zhang
Affiliation:1.Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China;2.Emergency Center, Beijing Tongren Hospital,Capital Medical University,Beijing,China;3.McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China;4.Department of Biochemistry, Faculty of Medicine and Dentistry,University of Alberta,Edmonton,Canada
Abstract:Cystic fibrosis (CF) is a rare disease most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. In this systematic review, we collected the clinical and genetic information of 71 Chinese CF patients based on all available data. Compared with Caucasians, Chinese CF patients often present atypical symptoms, mainly displaying symptoms of pulmonary infection with fewer digestive symptoms. An ethnicity-specific CFTR variant spectrum was also observed in CF patients of Chinese origin, with p.Gly970Asp as the most common mutation while p.Phe508del, the most common pathogenic mutation in CF patients of Caucasian origin, is rare, suggesting the necessity of a Chinese-specific CFTR variant screening panel. Besides, multiplex ligation-dependent probe amplification analysis should be routinely considered, especially for those with unidentified mutations. Potential under-diagnosis of CF in Chinese patients might be caused by a combination of atypical clinical features and genetic heterogeneity in Chinese CF patients, the inaccessibility of sweat and genetic testing facilities, and the one-child policy in China. With the approval of promising small molecule correctors and potentiators, molecular characterization of Chinese-specific CFTR mutations will help to realize more precise treatment for Chinese CF patients.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号